✦ LIBER ✦

Neuroprotection in Huntington's disease: Minocycline

✍ Scribed by R.M. Bonelli

Book ID: 119576350
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 245 KB
Volume: 12
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(02)80594-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Revisiting safety of minocycline as neur

Revisiting safety of minocycline as neuroprotection in Huntington's disease

✍ Norman Reynolds 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

Huntington's disease and minocycline

✍ Anna K. Hödl; Raphael M. Bonelli 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

## Abstract A reply to this letter has been published in __Movement__ DisordersMov Disord (2005) 20 (4) 511.

Minocycline beneficial in Huntington's d

Minocycline beneficial in Huntington's disease

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 155 KB

Minocycline: potential in Huntington's d

Minocycline: potential in Huntington's disease?

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 154 KB

Reply: Huntington's disease and minocycl

Reply: Huntington's disease and minocycline

✍ Madhavi Thomas; Tetsuo Ashizawa; J. Jankovic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

## Abstract The original letter to which this reply refers was published in __Movement__ DisordersMov Disord (2005) 20 (4) 510–511.

Minocycline in Huntington's disease: A p

Minocycline in Huntington's disease: A pilot study

✍ Madhavi Thomas; Tetsuo Ashizawa; Joseph Jankovic 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

## Abstract Minocycline is a caspase inhibitor, decreases inducible nitric oxide synthase (iNOS), and has been shown to delay disease progression in the mouse model R6/2 of Huntington's disease (HD). This safety and tolerability study included 30 patients with HD who were given minocycline over a 6